ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Swiss Asset Manager Insiders Buy the Dip as Rollins Peps Up

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Insider buying momentum is running hottest at ROL (Rollins), the pest control group, according to ORTEX data covering the past month. The stock is down 38% year-to-date. That kind of drawdown often draws opportunistic buying from people who know the business best.

Across the Atlantic, three European names showed meaningful insider activity in October. Partners Group, the Swiss private markets firm, led European insiders on the buying side. The stock has lost a third of its value this year. Directors bought into that weakness. Partners Group carries a 7.1% forward dividend yield, adding to the case insiders may have been making with their own money.

Sofina, the Belgian investment holding company, appeared on both the buying and selling lists over the past month. That two-way activity can reflect different insiders acting independently rather than a single mixed signal.

On the sell side, Roche Holding disclosed insider sales, the largest by value among European names. Roche is a $390 billion company, so large nominal sales by executives can still represent a small fraction of total holdings.

In Washington, Republican House member John McGuire III filed disclosures this week showing three separate purchases of MU (Micron Technology) between late September and early October, reported to regulators on 1 November. The transactions were each in the $1,000 to $15,000 range, so the dollar amounts are small. McGuire sits on the Armed Services committee. The pattern of repeated buys across consecutive weeks is worth noting, even at modest size.

Corebridge Financial also registered strong insider buying momentum in ORTEX data over the past month, with the stock up 18% year-to-date and a Q3 earnings call on the horizon.

Stocks in this article

How this article was generated

Generated
5 Nov 2026, 04:12
Prompt version
v1.0
Data sources
Institutional positioningAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.